Reaching the unreached: Performance of an enhanced peer outreach approach to identify new HIV cases among female sex workers and men who have sex with men in HIV programs in West and Central Africa.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 05 10 2018
accepted: 27 02 2019
entrez: 4 4 2019
pubmed: 4 4 2019
medline: 1 1 2020
Statut: epublish

Résumé

Finding new HIV-positive cases remains a priority to achieve the UNAIDS goals. An enhanced peer outreach approach (EPOA) was implemented to expand the delivery of HIV services to female sex workers (FSWs) and men who have sex with men (MSM) in three countries in West and Central Africa. The aim of EPOA is to identify new HIV-positive cases. EPOA was implemented in Burundi among FSWs, and in Cote d'Ivoire and Democratic Republic of the Congo (DRC) among both FSWs and MSM. Implementation ranged from five to nine weeks and was nested within a three-month reporting period. Standard outreach was suspended for the duration of EPOA implementation but was resumed thereafter. Summary service statistics were used to compare HIV seropositivity during standard outreach and EPOA. Trends were analyzed during the quarter in which EPOA was implemented, and these were compared with the two preceding quarters. Differences in proportions of HIV seropositivity were tested using Pearson's chi-square test; p-values of less than 0.05 were considered statistically significant. Overall, EPOA resulted in a higher proportion of new HIV-positive cases being found, both within and between quarters. In Burundi, HIV seropositivity among FSWs was significantly higher during EPOA than during standard outreach (10.8% vs. 4.1%, p<0.001). In Cote d'Ivoire, HIV seropositivity was significantly higher during EPOA among both populations (FSWs: 5.6% vs. 1.81%, p<0.01; MSM: 15.4% vs. 5.9%; p<0.01). In DRC, HIV seropositivity was significantly higher during EPOA among MSM (6.9% vs. 1.6%; p<0.001), but not among FSWs (5.2% vs. 4.3%; p = 0.08). Trends in HIV seropositivity during routine outreach for both populations were constant during three successive quarters but increased with the introduction of EPOA. EPOA is a public health approach with great potential for reaching new populations and ensuring that they are aware of their HIV status.

Identifiants

pubmed: 30943205
doi: 10.1371/journal.pone.0213743
pii: PONE-D-18-29009
pmc: PMC6447144
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0213743

Subventions

Organisme : PEPFAR
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):e162-9
pubmed: 24759065
J Urban Health. 2006 Nov;83(6 Suppl):i16-28
pubmed: 17031567
Clin Infect Dis. 2015 Dec 1;61(11):1732-41
pubmed: 26251048
Am J Reprod Immunol. 2013 Feb;69 Suppl 1:122-32
pubmed: 23387931
AIDS Res Treat. 2012;2012:815823
pubmed: 22666563
AIDS Behav. 2012 Feb;16(2):256-65
pubmed: 21390535
AIDS. 2006 Oct 3;20(15):1961-8
pubmed: 16988518
AIDS. 2015 Mar 13;29(5):583-93
pubmed: 25565495
AIDS Behav. 2015 Nov;19(11):1990-2000
pubmed: 25903507
Sex Transm Dis. 2013 Feb;40(2):168-74
pubmed: 23441335
AIDS Behav. 2008 Jul;12(4 Suppl):S131-41
pubmed: 18535901
J Int AIDS Soc. 2018 Jan;21(1):
pubmed: 29356365
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
J Urban Health. 2006 Nov;83(6 Suppl):i60-72
pubmed: 17066328
J Urban Health. 2010 Mar;87(2):304-317
pubmed: 20131018
Lancet. 2012 Jul 28;380(9839):367-77
pubmed: 22819660
BMJ Open. 2016 Feb 04;6(2):e010388
pubmed: 26846899
Lancet Infect Dis. 2013 Mar;13(3):214-22
pubmed: 23260128
AIDS. 2013 Nov 13;27(17):2665-78
pubmed: 23842129
Am J Public Health. 2009 Jun;99(6):1093-9
pubmed: 19372521

Auteurs

Tiffany A Lillie (TA)

FHI 360/LINKAGES, Washington, DC, United States of America.

Navindra E Persaud (NE)

FHI 360/LINKAGES, Washington, DC, United States of America.

Meghan C DiCarlo (MC)

FHI 360/LINKAGES, Washington, DC, United States of America.

Dismas Gashobotse (D)

FHI 360/LINKAGES, Bujumbura, Burundi.

Didier R Kamali (DR)

FHI 360/LINKAGES, Abidjan, Cote d'Ivoire.

Magda Cheron (M)

FHI 360/LINKAGES, Kinshasa, Democratic Republic of Congo.

Lirica Nishimoto (L)

FHI 360/LINKAGES, Washington, DC, United States of America.

Christopher Akolo (C)

FHI 360/LINKAGES, Washington, DC, United States of America.

Hally R Mahler (HR)

FHI 360/LINKAGES, Washington, DC, United States of America.

Maria C Au (MC)

U.S. Agency for International Development (USAID), Washington, DC, United States of America.

R Cameron Wolf (RC)

U.S. Agency for International Development (USAID), Washington, DC, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH